Aadi Biosciences | 10-Q: Q3 2024 Earnings Report
Aadi Biosciences | 8-K: Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lennon David James
Aadi Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aadi Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Neil Desai(8.5%)
Aadi Biosciences | 8-K: Current report
Aadi Biosciences | 8-K: Current report
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Desai Neil
Aadi Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.5%),Oleg Nodelman(7.5%), etc.
Aadi Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aadi Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Braden M Leonard(5.6%),BML Investment Partners, L.P.(4.8%)
Aadi Biosciences | 8-K: Current report
Aadi Biosciences | 8-K: Current report
Aadi Biosciences | 10-Q: Q2 2024 Earnings Report
Aadi Biosciences | 8-K: Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Desai Neil
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Desai Neil
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Reeve Emma
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Castelein Caley
Aadi Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Aghazadeh Behzad